Skip to content

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Status
Terminated
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01968876
Enrollment
68
Registered
2013-10-24
Start date
2013-10-30
Completion date
2017-11-14
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Dyslipidemia, Hypertension

Brief summary

This research will act as a pilot study that will be conducted to determine the effectiveness of a smartphone medication adherence application on adherence to oral hypertensive, diabetic, and dyslipidemic medications using a prospective randomized design. Subjects will be recruited from the University of Arkansas for Medical Sciences (UAMS) Internal Medicine Clinic North, and the study data will be collected using only subject self-reports and subject pharmacy records.

Interventions

OTHERMedication Adherence Smartphone App

MyMedSchedule is a consumer-grade smartphone application currently available on various marketplaces of the Android and iOS platforms that acts as a portal to the free service MyMedSchedule.com website. It can interface with the MedActionPlan discharge planning tool for providers by automatically populating fields, allowing medication lists to be pushed to a subject's MyMedSchedule account, allowing the input of complex medication regimens, and aiding in medication reconciliation. A MyMedSchedule account can be setup with the patient's name, date of birth, allergies, emergency contact, healthcare providers, insurance plan information, and complete medication list. Medication dose and refill reminders can be set and sent through short message service (SMS) text message or e-mail. SMS text message reminders will be used for this study.

Sponsors

University of Arkansas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females at least 18 years of age * Provide informed consent * Prescribed an oral medication indicated for hypertension, diabetes, or dyslipidemia during 12 weeks pre-enrollment * Own a smartphone (Android or iOS) with unlimited text messaging, email access, and app store access * Oral confirmation that the subject has not previously used a medication adherence app * Able to consult with a pharmacy or medical student during the recruitment process for purposes of consent, data collection, and/or medication reconciliation, and/or MyMedSchedule registration

Exclusion criteria

* Severely impaired vision * Reside in a nursing home * Non-ambulatory/bedridden * Not fluent in English

Design outcomes

Primary

MeasureTime frame
Change from baseline in number of pills taken over number of pills prescribed at 4 weeksChange from baseline to 4 weeks
Change from baseline in number of pills taken over number of pills prescribed at 12 weeksChange from baseline to 12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026